1. /
  2. About us /
  3. Our people and structure /
  4. Our people /
  5. Kate Allardice
Our people

Kate Allardice RN RM (she/her)

Senior Research Nurse – Disease Elimination

Working groups

kate.allardice@burnet.edu.au
Kate Allardice RN RM (she/her)

Background

Kate has a background in sexual health and blood borne viruses, midwifery and clinical research. She has a passion for working with people who may find it difficult to access mainstream healthcare.

Prior to joining Burnet, Kate worked as a nurse and midwife in Indigenous health in Alice Springs. She also worked in sexual health in Lismore, Melbourne and Darwin, and clinical research at the Royal Women’s Hospital in Melbourne and Melbourne Sexual Health Service.

Kate has worked on nurse-led outreach projects to provide hepatitis C testing and treatment to People Who Inject Drugs (PWID) since starting at Burnet. She has been the nursing lead on the PharmEC and QuickStart studies, both of which explore more equitable ways to provide testing and treatment of hepatitis C to PWIDs.  

Qualifications

  • 1980: Registered Nurse (hospital-based training) Royal Darwin Hospital
  • 2006: Graduate Diploma of Midwifery Deakin University and Eastern Health Box Hill Hospital

Positions

  • 2022: Senior Research Nurse – Disease Elimination, Burnet Institute
  • 2016: Research Nurse – Disease Elimination, Burnet Institute

Burnet publications

View 3 more
01 Jul 2024

Same-visit hepatitis C testing and treatment to accelerate cure among people who inject drugs (the QuickStart Study): a cluster randomised cross-over trial protocol

BMJ Open

Kate Allardice, Joseph Doyle, Katherine Heath, Imogen Elsum, Caitlin Douglass, Amanda Wade, Sally Von Bibra, Kico Chan, Beatriz Camesella, Rodney Guzman

01 Jul 2024

Same-visit hepatitis C testing and treatment to accelerate cure among people who inject drugs (the QuickStart Study): a cluster randomised cross-over trial protocol

BMJ Open

Kate Allardice, Joseph Doyle, Katherine Heath, Imogen Elsum, Caitlin Douglass, Amanda Wade, Sally Von Bibra, Kico Chan, Beatriz Camesella, Rodney Guzman

10 May 2022

Reaching people receiving opioid agonist therapy at community pharmacies with hepatitis C virus: an international randomised controlled trial

Alimentary Pharmacology & Therapeutics

Kate Allardice, Minh D. Pham, Joseph Doyle, Minh D. Pham, Kate Allardice, Joseph Doyle

Current projects

EXPAND-C: hepatitis C testing and treatment through community pharmacies

EXPAND-C: hepatitis C testing and treatment through community pharmacies

Expanding access to hepatitis C testing and treatment using a pharmacy-based model.

The QuickStart Study

The QuickStart Study

QuickStart aims to increase hepatitis C testing and treatment through rapid point-of-care tests and a same-day test-and-treat model in primary care settings.

Past projects

PharmEC REACH study: reaching methadone users attending community pharmacies with HCV

PharmEC REACH study: reaching methadone users attending community pharmacies with HCV

This project assesses the effectiveness, feasibility and cost-effectiveness of nurse-led testing and treatment of hepatitis C in community pharmacies for people on opiate substitution therapy.

The elimination of hepatitis C as a global public health threat

The elimination of hepatitis C as a global public health threat

This project addresses critical knowledge gaps in Australian and global efforts to eliminate hepatitis C as a public health threat by 2030.

News and features

Elimination of hepatitis C the focus of new funding grant

Elimination of hepatitis C the focus of new funding grant

On this page